Form 4 for INSM INSMED Inc

Accepted 2022-05-25 00:00:00 ET · period of report 2022-05-23 · accession 0001140361-22-020572 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-05-25	2022-05-23	INSM	Wise John Drayton	Chief Commercial Off	A - Grant	—	+26.2K	78.1K	+51%	—
D	2022-05-25	2022-05-23	INSM	Wise John Drayton	Chief Commercial Off	A - Grant	$0.00	+164.6K	164.6K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-05-23	A	A	26,236	—	78,137	D	—	—	(F1) Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant, subject to Mr. Wise's continued employment with the Company on each vesting date. (F2) Each Restricted Stock Unit was received as a grant on May 23, 2022, for no consideration.
2	Derivative	Stock Option (right to buy)	2022-05-23	A	A	164,580	$0.00	164,580	D	$20.01 · — to 2032-05-23	164,580 Common Stock	(F3) In connection with the appointment of Mr. Wise as the Company's Chief Commercial Officer, the Company granted Mr. Wise an option to purchase a total of 164,580 shares of the Company's common stock under the Company's 2019 Incentive Plan. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Mr. Wise's continued employment with the Company on each vesting date.